[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-161760-105":3,"detail-sidebar-cat-1-en-105":80,"doc-detail-161760-en":126},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","executive-summary-dsmc-data-and-safety-monitoring-committee-report-report-template","Executive Summary - DSMC Data and Safety Monitoring Committee Report - Report Template","","Executive Summary section template for a Data and Safety Monitoring Committee (DSMC) report, organized to support consistent review of study progress and participant safety. Includes placeholders for protocol synopsis, report overview, responses to recent DSMC recommendations, enrollment and subject status, baseline characteristics, and safety summary components. Guides authors to update headings, populate enrollment and milestone summaries, summarize adverse events and deaths, document laboratory and clinical findings, and record protocol deviations, quality management, and outcomes data. Structured appendices reference additional tables, figures, and data listings.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/presentations/","Presentations",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/executive-summary-dsmc-data-and-safety-monitoring-committee-report-report-template/161760/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/executive-summary-dsmc-data-and-safety-monitoring-committee-report-report-template/161760.png","ImageObject",442,249,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-19","2026-08-30",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What information does the Executive Summary section collect for the DSMC report?","Question",{"text":62,"@type":63},"It consolidates the study’s key context and findings, including protocol synopsis, report overview, and core safety and enrollment highlights, with placeholders for authors to insert the latest study information.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How should DSMC recommendations or requests from the most recent meeting be handled?",{"text":67,"@type":63},"The template prompts authors to identify the DSMC recommendations/requests from the last meeting and clarify how each was addressed in this report or elsewhere, noting if no prior requests exist.",{"name":69,"@type":60,"acceptedAnswer":70},"What topics are included in the Safety Summary section?",{"text":71,"@type":63},"The template includes stopping rules, deaths, unanticipated problems, adverse events and serious adverse events, laboratory findings, other clinical tests, and related documentation such as protocol deviations and safety-focused outcomes context.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},161760,1788109116,{"code":4,"msg":81,"data":82},"success",[83,87,92,97,102,107,112,117,122],{"id":84,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":85,"slug":86},11,90,"presentations",{"id":88,"doc_module":22,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},12,"Resumes",80,"resumes",{"id":93,"doc_module":22,"doc_module_name":25,"category_name":94,"show_sort_weight":95,"slug":96},14,"Invoices",70,"invoices",{"id":98,"doc_module":22,"doc_module_name":25,"category_name":99,"show_sort_weight":100,"slug":101},15,"Posters",60,"posters",{"id":103,"doc_module":22,"doc_module_name":25,"category_name":104,"show_sort_weight":105,"slug":106},16,"Social Media",50,"social-media",{"id":108,"doc_module":22,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},17,"Forms",40,"forms",{"id":113,"doc_module":22,"doc_module_name":25,"category_name":114,"show_sort_weight":115,"slug":116},18,"Letters",30,"letters",{"id":118,"doc_module":22,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},21,"Paper Templates",5,"papers-templates",{"id":123,"doc_module":22,"doc_module_name":25,"category_name":124,"show_sort_weight":4,"slug":125},158,"General","general-158",{"code":4,"msg":81,"data":127},{"doc_id":78,"user_id":128,"nickname":42,"user_avatar":129,"doc_module":22,"category_id":84,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":103,"language":135,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":12,"update_tm":79,"read_time":139},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Tool Summary Sheet\nTool Revision History:\n\u000fData AND Safety Monitoring Committee Report\nTable of Contents\n{This table uses the Table of Contents function in Microsoft Word that will automatically update headings and page numbers used in the body of the report. In the body of the report, add, delete, or modify headings as needed in order to best reflect your study.}\n\u0013 TOC \\o \"1-3\" \\h \\z \\u \u0014\u0013 HYPERLINK \\l \"_Toc204329589\" \u0014Executive Summary\t\u0013 PAGEREF _Toc204329589 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329590\" \u0014Protocol Synopsis\t\u0013 PAGEREF _Toc204329590 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329591\" \u00141.0\tReport Overview\t\u0013 PAGEREF _Toc204329591 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329592\" \u00142.0\tResponse to Most Recent DSMC Recommendations/Requests\t\u0013 PAGEREF _Toc204329592 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329593\" \u00143.0\tEnrollment Status\t\u0013 PAGEREF _Toc204329593 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329594\" \u00144.0\tSubject Status\t\u0013 PAGEREF _Toc204329594 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329595\" \u00145.0\tBaseline Characteristics\t\u0013 PAGEREF _Toc204329595 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329596\" \u00146.0\tSafety Summary\t\u0013 PAGEREF _Toc204329596 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329597\" \u00146.1\tStopping Rules\t\u0013 PAGEREF _Toc204329597 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329598\" \u00146.2\tDeaths\t\u0013 PAGEREF _Toc204329598 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329599\" \u00146.3\tUnanticipated Problems\t\u0013 PAGEREF _Toc204329599 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329600\" \u00146.4\tAdverse Events\t\u0013 PAGEREF _Toc204329600 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329601\" \u00146.5\tSerious Adverse Events\t\u0013 PAGEREF _Toc204329601 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329602\" \u00146.6\tLaboratory Findings\t\u0013 PAGEREF _Toc204329602 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329603\" \u00146.7\tOther Clinical Tests\t\u0013 PAGEREF _Toc204329603 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329604\" \u00147.0\tProtocol Deviations\t\u0013 PAGEREF _Toc204329604 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329605\" \u00148.0\tQuality Management\t\u0013 PAGEREF _Toc204329605 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329606\" \u00149.0\tOutcomes Data\t\u0013 PAGEREF _Toc204329606 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329607\" \u0014Appendix A: Additional Summary Tables\t\u0013 PAGEREF _Toc204329607 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329608\" \u0014Appendix B: Additional Figures\t\u0013 PAGEREF _Toc204329608 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc204329609\" \u0014Appendix C: Additional Data Listings\t\u0013 PAGEREF _Toc204329609 \\h \u001416\u0015\u0015\n\u0015\nExecutive Summary\n{Add, delete, or modify summary topics as needed.}\n\u000fProtocol Synopsis\n{Add, delete, or modify protocol headings as required.  Enter appropriate information in second column; some clarification guidance has been provided.}\n\u000f{Add, delete, or modify headings as needed in order to best reflect your study. Place summary tables, listings, and figures within the body of the report; however, if the tables, listings, or figures are long, place them in the Appendices. For small numbers of subjects, listings may be more appropriate than summary tables.}\nReport Overview\n{Example text:}\nThe purpose of this report is to review cumulative enrollment and safety data for the subjects enrolled in the Excellent study. This report reflects data from the study database as of April 19, 2010. Within the body of the report are summary tables of enrollment, demographic characteristics, and adverse events. Additional tables, listings, and figures referenced in this report are provided in Appendices A-C. There have been five DSMC meetings for this study, and the last review was on April 10, 2009. At that time, the DSMC concluded that the available safety data supported the continuation of the trial. Readers of this report are asked to maintain the confidentiality of the information provided in this report.\nResponse to Most Recent DSMC Recommendations/Requests\n{Identify DSMC recommendations/requests from the last meeting and clarify how those requests have been handled in the report and/or elsewhere.  If this is the first DSMC meeting for this protocol or no previous recommendations/requests were made, indicate as such in this section.  Doing so will provide a future reminder to the author who is likel","cbCaied0pYWzf1G1","https://ap.wps.com/l/cbCaied0pYWzf1G1","docx",276320,"English","# Executive Summary\n## Protocol Synopsis\n## Report Overview\n## Response to Most Recent DSMC Recommendations/Requests\n## Enrollment Status\n## Subject Status\n## Baseline Characteristics\n## Safety Summary\n### Stopping Rules\n### Deaths\n### Unanticipated Problems\n### Adverse Events\n### Serious Adverse Events\n### Laboratory Findings\n### Other Clinical Tests\n## Protocol Deviations\n## Quality Management\n## Outcomes Data\n## Appendix A: Additional Summary Tables\n## Appendix B: Additional Figures\n## Appendix C: Additional Data Listings","[{\"question\":\"What information does the Executive Summary section collect for the DSMC report?\",\"answer\":\"It consolidates the study’s key context and findings, including protocol synopsis, report overview, and core safety and enrollment highlights, with placeholders for authors to insert the latest study information.\"},{\"question\":\"How should DSMC recommendations or requests from the most recent meeting be handled?\",\"answer\":\"The template prompts authors to identify the DSMC recommendations/requests from the last meeting and clarify how each was addressed in this report or elsewhere, noting if no prior requests exist.\"},{\"question\":\"What topics are included in the Safety Summary section?\",\"answer\":\"The template includes stopping rules, deaths, unanticipated problems, adverse events and serious adverse events, laboratory findings, other clinical tests, and related documentation such as protocol deviations and safety-focused outcomes context.\"}]","Executive Summary - DSMC Data and Safety Monitoring Committee Report - Report Template | DOCX",6]